A maturing 2 FDA landscape Many organizations are increasing their focus on FDA deployment, with increased spending on advanced tools and proactive monitoring of larger volumes of data. However, some are failing to recognize that the value FDA can bring to anti-fraud programs goes beyond just detection and investigation. 12 | Global Forensic Data Analytics Survey 2016